AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large...
113 insider purchases on record · latest filing 2025-06-16.
Insiders have also filed 31 sale transactions at AIM.